Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms

Gynecologic Oncology

Volumn 115, Issue 1, 2009, Pages 121-126

  Noskova, Vera ^a   Ahmadi, Sara ^a   Åsander, Eleonor ^a   Casslén, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

bFGF; Co cultures; EGF; Epithelial stromal interaction; HGF; Tumor microenvironment

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; SCATTER FACTOR; SOMATOMEDIN C;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CONTROLLED STUDY; GENE INDUCTION; HUMAN; HUMAN CELL; MICROENVIRONMENT; OVARY CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL;

ADENOCARCINOMA; CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; RNA, MESSENGER; STROMAL CELLS; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 69249215169     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.06.026     Document Type: Article

References (56)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
2. Mueller M.M., and Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4 (2004) 839-849
3. De Wever O., and Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol. 200 (2003) 429-447
4. Micke P., and Ostman A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?. Lung Cancer 45 (2004) S163-S175
5. Kopfstein L., and Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell. Mol. Life Sci. 63 (2006) 449-468
6. Beacham D.A., and Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin. Cancer Biol. 15 (2005) 329-341
7. Andreasen P.A., Egelund R., and Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57 (2000) 25-40
8. Borgfeldt C., Hansson S.R., Gustavsson B., Masback A., and Casslen B. Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1). Int. J. Cancer 92 (2001) 497-502
9. Borgfeldt C., Casslen B., Liu C.L., Hansson S., Lecander I., and Astedt B. High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma. Int. J. Cancer 79 (1998) 588-595
10. Cunha G.R., Cooke P.S., and Kurita T. Role of stromal-epithelial interactions in hormonal responses. Arch. Histol. Cytol. 67 (2004) 417-434
11. Elenbaas B., and Weinberg R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell. Res. 264 (2001) 169-184
12. Corso S., Comoglio P.M., and Giordano S. Cancer therapy: can the challenge be MET?. Trends Mol. Med. 11 (2005) 284-292
13. Bauer T.W., Liu W., Fan F., Camp E.R., Yang A., Somcio R.J., et al. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res. 65 (2005) 7775-7781
14. Apte R., Dotan S., Elkabets M., White M.R., Reich E., Carmi Y., et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25 (2006) 387-408
15. Singh A.B., and Harris R.C. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell. Signal. 17 (2005) 1183-1193
16. Miyamoto S., Yagi H., Yotsumoto F., Kawarabayashi T., and Mekada E. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Science 97 (2006) 341-347
17. Rosenquist C., Thorpe S.M., Dano K., and Grondahl-Hansen J. Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue. Breast Cancer Res. Treat. 28 (1993) 223-229
18. Plesner T., Ploug M., Ellis V., Rønne E., Høyer-Hansen G., and Wittrup M. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 83 (1994) 808-815
19. Giulianelli S., Cerliani J.P., Lamb C.A., Fabris V.T., Bottino M.C., Gorostiaga M.A., et al. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: a role for the FGF-2/FGFR-2 axis. Int. J. Cancer 123 11 (2008) 2518-2531
20. Acevedo V.D., Ittmann M., and Spencer D.M. Paths of FGFR-driven tumorigenesis. Cell Cycle 8 (2009) 580-588
21. Davidson B., Goldberg I., Gotlieb W.H., Kopolovic J., Ben-Baruch G., Nesland J.M., et al. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol. Cell. Endocrinol. 187 (2002) 39-45
22. Barton D.P., Cai A., Wendt K., Young M., Gamero A., and De Cesare S. Angiogenic protein expression in advanced epithelial ovarian cancer. Clin. Cancer Res. 3 (1997) 1579-1586
23. Gohda E., Matsunaga T., Kataoka H., Takebe T., and Yamamoto I. Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor. Cytokine 6 (1994) 633-640
24. Mignatti P., Mazzieri R., and Rifkin D.B. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell. Biol. 113 (1991) 1193-1201
25. Besser D., Presta M., and Nagamine Y. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell. Growth Differ. 6 (1995) 1009-1017
26. Cavallaro U., Wu Z., Di Palo A., Montesano R., Pepper M.S., Maier J.A., et al. FGF-2 stimulates migration of Kaposi's sarcoma-like vascular cells by HGF-dependent relocalization of the urokinase receptor. FASEB J. 12 (1998) 1027-1034
27. Ingram J.L., and Bonner J.C. EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseases. Curr. Mol. Med. 6 (2006) 409-421
28. Wells A., Ware M.F., Allen F.D., and Lauffenburger D.A. Shaping up for shipping out: PLCgamma signaling of morphology changes in EGF-stimulated fibroblast migration. Cell. Motil. Cytoskeleton 44 (1999) 227-233
29. Sorkin A., and Waters C.M. Endocytosis of growth factor receptors. Bioessays 15 (1993) 375-382
30. Fischer-Colbrie J., Witt A., Heinzl H., Fischer-Colbrie J., Witt A., Heinzl H., et al. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res. 7 (1997) 613-619
31. Sandberg T., Ehinger A., and Casslen B. Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor. J. Clin. Endocrinol. Metab. 86 (2001) 1724-1730
32. Jo M., Thomas K.S., Marozkina N., Amin T.J., Silva C.M., Parsons S.J., et al. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. J. Biol. Chem. 280 (2005) 17449-17457
33. Henic E., Sixt M., Hansson S., Hoyer-Hansen G., and Casslen B. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Gynecol. Oncol. 101 (2006) 28-39
34. Guerrero J., Santibanez J.F., Gonzalez A., and Martinez J. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp. Cell. Res. 292 (2004) 201-208
35. Jo M., Thomas K.S., Takimoto S., Gaultier A., Hsieh E.H., Lester R.D., et al. Urokinase receptor primes cells to proliferate in response to epidermal growth factor. Oncogene 26 (2007) 2585-2594
36. Iwamoto R., and Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 11 (2000) 335-344
37. Miyamoto S., Hirata M., Yamazaki A., Kageyama T., Hasuwa H., Mizushima H., et al. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res. 64 (2004) 5720-5727
38. Iwamoto R., Yamazaki S., Asakura M., Takashima S., Hasuwa H., Miyado K., et al. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3221-3226
39. Giri D., and Ittmann M. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am. J. Pathol. 157 (2000) 249-255
40. Chou H.H., Takashiba S., Maeda H., et al. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts. J. Dent. Res. 79 (2000) 1683-1688
41. Nozaki S., Sledge Jr. G.W., and Nakshatri H. Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem. Biophys. Res. Commun. 275 (2000) 60-62
42. Blom S., Holmstrup P., and Dabelsteen E. The effect of insulin-like growth factor-I and human growth hormone on periodontal ligament fibroblast morphology, growth pattern, DNA synthesis, and receptor binding. J. Periodontol. 63 (1992) 960-968
43. Druckmann R., and Rohr U.D. IGF-1 in gynaecology and obstetrics: update 2002. Maturitas 41 (2002) S65-S83
44. Conover C.A., Hartmann L.C., Bradley S., Stalboerger P., Klee G.G., Kalli K.R., et al. Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. Exp. Cell. Res. 238 (1998) 439-449
45. Matsuzaki H., Kobayashi H., Yagyu T., Wakahara K., Kondo T., Kurita N., et al. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism. Oncol. Rep. 14 (2005) 449-457
46. Brokaw J., Katsaros D., Wiley A., Lu L., Su D., Sochirca O., et al. IGF-I in epithelial ovarian cancer and its role in disease progression. Growth Factors 25 (2007) 346-354
47. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell. Biol. 4 (2003) 915-925
48. Nakamura T., Matsumoto K., Kiritoshi A., and Tano Y. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57 (1997) 3305-3313
49. Maier J., Mariotti M., Comoglio P.M., and Soria M.R. Interleukin 1 induces an autocrine loop hepatocyte growth factor/c-Met in murine Kaposi-like spindle cells. Oncogene 13 (1996) 1009-1015
50. Rosova I., Dao M., Capoccia B., Link D., and Nolta J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem. Cells 26 (2008) 2173-2182
51. Jeffers M., Rong S., and Vande Woude G.F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol. 16 (1996) 1115-1125
52. Mars W.M., Zarnegar R., and Michalopoulos G.K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 143 (1993) 949-958
53. Matsuoka H., Sisson T.H., Nishiuma T., and Simon R.H. Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix. Am. J. Respir. Cell. Mol. Biol. 35 (2006) 705-713
54. Yoshida S., Harada T., Iwabe T., Taniguchi F., Fujii A., Sakamoto Y., et al. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer. J. Clin. Endocrinol. Metab. 87 (2002) 2376-2383
55. Huntsman D., Resau J.H., Klineberg E., and Auersperg N. Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy. Am. J. Pathol. 155 (1999) 343-348
56. Lesko E., and Majka M. The biological role of HGF-MET axis in tumor growth and development of metastasis. Front. Biosci. 13 (2008) 1271-1280